Literature DB >> 26069316

European Healthy Cities come to terms with health network governance.

Evelyne de Leeuw1, Ilona Kickbusch2, Nicola Palmer3, Lucy Spanswick3.   

Abstract

A focus on good governance in the WHO European network of Healthy Cities mirrors the WHO Region's strategic emphasis-its member states in the Health 2020 strategy espouse governance for health as key. Healthy Cities adopted governance as a key value and approach to delivering specific health programmes and policies. This article reviews the extent to which they actually introduce and align governance concepts and approaches with their local government commitments. Healthy Cities show that better participation, policy-making and intersectoral action result from an emphasis on governance. This happens across the designated cities and is not limited to a certain class (in terms of population or geographical location) or the time they have been designated. The support of WHO in driving the governance agenda seems important, but no data are available to show that European Healthy Cities are different from other urban environments.
© The Author 2015. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Keywords:  Europe; governance; health policy; healthy cities

Mesh:

Year:  2015        PMID: 26069316     DOI: 10.1093/heapro/dav040

Source DB:  PubMed          Journal:  Health Promot Int        ISSN: 0957-4824            Impact factor:   2.483


  2 in total

1.  Health Impact Assessments in Spain: Have They Been Effective?

Authors:  Maite Morteruel; Amaia Bacigalupe; Elena Aldasoro; Isabel Larrañaga; Elena Serrano
Journal:  Int J Environ Res Public Health       Date:  2020-04-24       Impact factor: 3.390

2.  Engaging Diverse Community Groups to Promote Population Health through Healthy City Approach: Analysis of Successful Cases in Western Pacific Region.

Authors:  Albert Lee; Keiko Nakamura
Journal:  Int J Environ Res Public Health       Date:  2021-06-19       Impact factor: 3.390

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.